Fintel reports that on January 23, 2025, Barclays initiated coverage of Guardant Health (NasdaqGS:GH) with a Overweight ...

We recently compiled a list of the 10 Firms Kick Off Trading Week Soaring. In this article, we are going to take a look at ...

Guardant Health, Inc. (NASDAQ:GH) announced that Palmetto GBA, a Medicare administrative contractor that administers the ...

Despite Guardant Health's positive Q4 2024 report, it remains unprofitable with negative cash flow, unlike its peer Natera.

In terms of valuation, Guardant Health Inc’s market capitalization stands at $6.00 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market ...

Barclays initiated coverage of Guardant Health (GH) with an Overweight rating and $60 price target The firm started the liquid biopsy space ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on GH stock, giving a Buy rating yesterday.Invest with Confidence: ...

Guardant Health stock hit a 13-month high Tuesday after Medicare officials agreed to pay for the company's colon cancer blood ...

Guardant Health Inc (GH) stock saw a modest uptick, ending the day at $45.13 which represents a slight increase of $8.47 or 23.10% from the prior close of $36.66. The stock opened at $39.04 and ...

In an early look at its annual earnings report, Guardant Health posted revenue gains of 31%—with the $737 million total ...

The analyst from Canaccord Genuity noted Guardant Health (NASDAQ:GH)'s extensive experience in blood-based cancer detection ...

Wealthcare Advisory Partners LLC acquired a new position in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities ...